Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-015-0 | CAS number: 25470-96-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute median lethal oral dose (LD50) to rats of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium was demonstrated to be greater than 2000 mg/kg body weight. The substance does not need to a classification for acute toxicity under EU CLP.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 July 2020 - 12 August 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Version / remarks:
- 17 Dec 2001
- Deviations:
- yes
- Remarks:
- temperature in animal room was 20 - 26°C instead of 20 - 24°C for several hours on several days due to insufficient capacity of the air conditioning system during a summer heat wave. This deviation does not affect the validity of the study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Version / remarks:
- 30 May 2008
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- purity: 100%
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Wistar Han
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Source: Janvier Labs CS4105 Le Genest Saint Isle 53941 Saint Berthevin Cedex / France
Females were nulliparous and non-pregnant, Age (beginning of treatment) 8 - 12 weeks
At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
Housing: groups of one to five rats (of the same sex and dose group)
Cage Type: Makrolon Type IV, with wire mesh top
Bedding: granulated soft wood bedding
Feed: 2018C Teklad Global 18% protein rodent diet
(certified), ad libitum
(except for overnight fasting prior to dosing; diet was returned immediately after dosing was complete)
Water: tap water, ad libitum
Environment: temperature 22 + 2°C (except for deviations)
relative humidity approx. 45-65%
(with the aim of 50 – 60%)
artificial light 6.00 a.m. - 6.00 p.m.
ventilation: at least eight air changes per hour
Environmental enrichment: provided throughout the study period (e.g., wooden chew blocks, fun tunnels or suitable nesting material) - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The different test item concentrations were prepared individually. Homogeneity of the test item in vehicle was maintained during treatment using a magnetic stirrer.
The test item was formulated at a concentration of 30 and 200 mg/mL in the vehicle and administered at a constant dose volume of 10 mL/kg body weight. Grinding of the test item in a mortar was used to formulate the test item.
Test substance formulations were freshly prepared on the day of dosing, issued at room temperature and administered as soon as possible (within 4 hours of preparation). The formulations were assumed to be stable for this period unless specified otherwise by the Sponsor.
Samples of test substance formulations were not taken for analysis and consequently the homogeneity, concentration and stability of the test item were not determined. - Doses:
- Dose administration was once orally by gavage (feeding needle). The volume administered did not exceed 10 mL/kg b.w.
In the absence of data regarding the toxicity of the test item 300 mg/kg was chosen as the initial starting dose, since a severe toxicity which may necessitate humane euthanasia was not expected at this dose level.
Two single animals were treated as follows:
Dose level (mg/kg) Concentration (mg/mL) Dose volume (mL/kg) Number of rats
Female
300 30 10 1
2000 200 10 1
In the absence of mortality or toxicity at a dose level of 2000 mg/kg, an additional group of animals was treated as follows:
Dose level (mg/kg) Concentration (mg/mL) Dose volume (mL/kg) Number of rats
Female
2000 200 10 4
A total of five animals were therefore treated at a dose level of 2000 mg/kg in the study. - No. of animals per sex per dose:
- 4 females at the maximum tolerated dose
- Control animals:
- no
- Details on study design:
- Clinical observations and inspections for morbidity / mortality were performed at least three times within the first six hours after application (i.e., 30 minutes and 1 hour, 2 hours and 4 hours after dosing), thereafter at least once daily for 14 days. All animals were observed for 14 days after dosing.
The nature and severity, where appropriate, of the clinical signs and the time were recorded at each observation for all individual animals. If applicable, the time of death/humane kill was recorded as precisely as possible. Observations included changes in the skin and fur, eyes and mucous membranes, and respiratory, circulatory, autonomic and central nervous system, and somatomotor activity and behavior pattern. Particular attention was directed to the observation of tremors, convulsions, salivation, diarrhea, lethargy, sleep and coma.
Animals were sacrificed by carbon dioxide asphyxiation followed by cervical dislocation.
Body weights were recorded on Day 0 (prior to dosing), Day 7, and 14, or (if applicable) at death (unscheduled).
A gross necropsy was performed on all animals that died or were humanely killed during the study (if applicable) and at the end of the in-life part. Any macroscopic abnormalities were recorded. Routinely no organs or tissues were retained. - Statistics:
- The test item is classified according to Annex 3 of the OECD Guidelines for Testing of Chemicals No. 420 ‘Acute Oral Toxicity – Fixed Dose Procedure’ (adopted 17 December 2001) as shown in the Flow Chart in Annex 2.
Evaluation of data includes the identification of the number of animals that died during the study (or that were killed for humane reasons), and determination of the nature, severity, onset and duration of the toxic effects. If possible, the signs of toxic effects of evident toxicity are described. Evident toxicity refers to the toxic effects of sufficient severity that administration of the next higher dose level could result in development of severe signs of toxicity and probable mortality. Effects on body weights and abnormalities noted at necropsy were identified.
Using the mortality data obtained, an estimate of the acute oral median lethal dose (LD50) of the test item was made. - Preliminary study:
- In the absence of data regarding the toxicity of the test item 300 mg/kg was chosen as the initial starting dose, since a severe toxicity which may necessitate humane euthanasia was not expected at this dose level.
Two single animals were treated as follows:
Dose level (mg/kg) Concentration (mg/mL) Dose volume (mL/kg) Number of rats
Female
300 30 10 1
2000 200 10 1
In the absence of mortality or toxicity at a dose level of 2000 mg/kg, an additional group of animals was treated as follows:
Dose level (mg/kg) Concentration (mg/mL) Dose volume (mL/kg) Number of rats
Female
2000 200 10 4
A total of five animals were therefore treated at a dose level of 2000 mg/kg in the study. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths during the study.
- Clinical signs:
- other: There were no clinical signs of reaction to treatment throughout the study.
- Gross pathology:
- 300 mg/kg: Enlarged mesenteric lymphnodes were noted for this animal.
2000 mg/kg: In one animal (animal numer 2) increased fat tissue in the abdomen was noted. No abnormalities were noted in any other animal at the macroscopic examination. - Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The acute median lethal oral dose (LD50) to rats of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium was demonstrated to be greater than 2000 mg/kg body weight. The substance does not need to a classification for acute toxicity under EU CLP.
- Executive summary:
A study was performed to assess the acute oral toxicity of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium to the rat.
Following a sighting test at dose levels of 300 mg/kg b.w. and 2000 mg/kg b.w. in one female rat per dose group, a further group of four fasted females was given a single oral dose of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium, as a suspension in corn oil, at a dose level of 2000 mg/kg body weight. Clinical signs and body weight development were monitored in all animals during the study. All animals were subjected to gross necropsy.
Mortality: There were no deaths.
Clinical Observations: There were no signs of systemic toxicity noted in the animals.
Body Weight:All animals showed expected gains in body weight.
Necropsy:In the animal treated with 300 mg/kg b.w. enlarged mesenteric lymphnodes were noted and in one animal treated with 2000 mg/kg b.w. increased fat tissue in the abdomen was noted. No abnormalities were noted in the remaining animals.
The acute median lethal oral dose (LD50) to rats of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium was demonstrated to be greater than 2000 mg/kg body weight. Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium is not classified under EU CLP.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
The acute median lethal oral dose (LD50) to rats of Carbonyl(pentane-2,4-dionato-O,O’) (triphenylphosphine)rhodium was demonstrated to be greater than 2000 mg/kg body weight. The substance does not need to a classification for acute toxicity under EU CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.